Beta-Alanine Supplementation for PTSD Resilience
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for post-traumatic stress disorder (PTSD) are limited in preventing or increasing resilience to the condition, and there is a need for effective dietary supplements that can improve physiological responses related to PTSD.
Innovation Solution
Supplementation with the free amino acid beta-alanine, or its salt, administered over a period of time to increase brain carnosine concentrations and maintain brain-derived neurotrophic factor (BDNF) expression, thereby reducing PTSD-like behaviors and symptoms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for PTSD are used, then existing therapeutic options are provided, but effectiveness in preventing or increasing resilience to PTSD is limited
Solution Approach 1:
The patent changes the chemical parameter by introducing beta-alanine supplementation to increase brain carnosine concentrations. This parameter change (increased carnosine levels) leads to improved physiological responses and increased resilience to PTSD symptoms, thereby resolving the contradiction between treatment effectiveness and adaptability.
2Reliability
If beta-alanine is supplemented over a period of time, then brain carnosine concentrations increase and BDNF expression is maintained, but the supplementation requires continuous administration
Solution Approach 1:
The patent applies preliminary action by administering beta-alanine supplementation before PTSD symptoms fully develop or worsen. By maintaining brain carnosine concentrations through advance supplementation, the treatment prevents the need for more intensive interventions later, thereby resolving the contradiction between achieving reliable brain carnosine levels and minimizing time loss.
3Ease of operation
If beta-alanine supplementation is administered, then anxiety and PTSD-like behaviors are reduced, but the mechanism involves complex neurochemical changes including BDNF expression and serotonin concentration changes
Solution Approach 1:
The patent uses brain carnosine as an intermediary substance that mediates the effect of beta-alanine supplementation on PTSD symptoms. Beta-alanine increases brain carnosine concentrations, which in turn maintains BDNF expression and modulates serotonin concentrations, ultimately reducing anxiety and PTSD-like behaviors. This intermediary mechanism simplifies the operational approach while managing the underlying neurochemical complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The beta-alanine supplementation effectively increases brain carnosine levels and maintains BDNF expression, leading to reduced anxiety, improved behavioral performance, and increased resilience to PTSD-like behaviors in animal models.
Implementation Method 1
when consumed in sufficient dosages over time, β-alanine combines in the skeletal muscle with L-histidine to form the dipeptide carnosine (beta-alanylhistidine)
Implementation Method 2
The primary role of carnosine is in the maintenance of acid-base homeostasis through enhanced intra-muscular hydrogen ion (H+) buffering
Implementation Method 3
recent research has demonstrated that β-alanine can increase carnosine concentrations in the brain resulting in a decrease in serotonin concentrations, increase brain-derived neurotrophic factor
Implementation Method 4
Carnosine's biological role as an antioxidant, an antiglycating and ion-chelating agent suggests that it may have a potential role in neuroprotection during oxidative stress
Data Source
Figure 1A~1B
Figure 1C~1D
Figure 2A
AI summary
The present invention provides methods of improving physiological responses related to post-traumatic stress disorder, wherein the free amino acid beta-alanine, or a salt or ester thereof, is administered to an individual as a human dietary supplement over a period of time in an amount effective to improve physiological responses related to post-traumatic stress disorder.